8-Hydroxy-2-deoxy-guanosine identifies oxidative DNA damage in a rural prediabetes cohort

Redox Report

Volumn 15, Issue 4, 2010, Pages 155-160

  Al Aubaidy, Hayder A ^a,b   Jelinek, Herbert F ^a,c  

^a CHARLES STURT UNIVERSITY   (Australia)

^b AL NAHRAIN UNIVERSITY   (Iraq)

^c Centre for Research in Complex Systems   (Australia)

Author keywords

8 Hydroxy 2 deoxy guanosine; erythrocyte reduced glutathione; oxidative DNA damage; prediabetes; type 2 diabetes

Indexed keywords

8 HYDROXYDEOXYGUANOSINE; CHOLESTEROL; GLUCOSE; GLUTATHIONE; MALONALDEHYDE;

ANTIOXIDANT ACTIVITY; ARTICLE; BLOOD VESSEL WALL; BODY MASS; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CHOLESTEROL BLOOD LEVEL; COHORT ANALYSIS; CONTROLLED STUDY; DISEASE MARKER; DNA DAMAGE; GLUCOSE BLOOD LEVEL; HUMAN; IMPAIRED GLUCOSE TOLERANCE; LIPID PEROXIDATION; MAJOR CLINICAL STUDY; NON INSULIN DEPENDENT DIABETES MELLITUS; OXIDATIVE STRESS; PRIORITY JOURNAL; RURAL POPULATION;

AGED; CASE-CONTROL STUDIES; DEOXYGUANOSINE; DIABETES MELLITUS, TYPE 2; DNA DAMAGE; FEMALE; HUMANS; MALE; MALONDIALDEHYDE; MIDDLE AGED; PREDIABETIC STATE;

EID: 77955065596     PISSN: 13510002     EISSN: 17432928     Source Type: Journal    
DOI: 10.1179/174329210X12650506623681     Document Type: Article

References (44)

1. Mehta JL, Rasouli N, Sinha AK, Molavi B. Oxidative stress in diabetes: a mechanistic overview of its effects on atherogenesis and myocardial dysfunction. Int J Biochem Cell B 2006; 38:794-803.
2. Huebschmann AG, Regensteiner JG, Vlassara H, Reusch JEB. Diabetes and advanced glycoxidation end products. Diabetes Care 2006; 29: 1420-1432.
3. Sheetz MJ, King GL. Molecular understanding of hyperglycemia's adverse effects of diabetic complications. JAMA 2002; 288: 255579-1252589
4. Nwose E, Jelinek H, Richards R, Kerr P. Oxidative stress and related cardiovascular events: Biomarkers improve CAD screening in prediabetes. BrJBiomedSci 2007; 64: 35-43.
5. Hinokio Y Suzuki S, Hirai M, Suzuki C, Suzuki M, Toyota T. Urinary excretion of 8-oxo-7,8-dihydro-2-deoxyguanosine as a predictor of the development of diabetic nephropathy. Diabetologia 2002; 45:877-882.
6. Akhtar N. Is homocysteine a risk factor for atherothrombotic cardiovascular disease? J Am Coll Cardiol 2007; 49:1370-1371.
7. Stocker R, Keaney JF. Role of oxidative modifications in atherosclerosis. Physiol Rev 2004; 84:1381-1478.
8. Nwose EU, Jelinek HF, Richards RS, Kerr PG. Erythrocyte oxidative stress in clinical management of diabetes and its cardiovascular complication: a review. Br JBiomed Sci 2007; 64: 35-43.
9. Nwose EU, Jelinek HF, Richards RS, Kerr PG. Changes in the erythrocyte glutathione concentration in the course of diabetes mellitus. Redox Rep 2006; 11:99-104.
10. Cersosimo E, DeFronzo RA. Insulin resistance and endothelial dysfunction: the road map to cardiovascular diseases. Diabetes Metab Res 2006; 22: 423-436.
11. Kopprasch S, Pietzsch J, Kuhlisch E et al. In vivo evidence for increased oxidation of circulating LDL in impaired glucose tolerance. Diabetes 2002; 51: 3102-3106.
12. Wright E, Scism-Bacon JL, Glass LC. Oxidative stress in type 2 diabetes: the role of fasting and postprandial glycaemia. Int J Clin Pract 2006; 60: 308-314.
13. Yoshida K, Hirokawa J, Tagami S, Kawakami Y Urata Y Kondo T. Weakened cellular scavenging activity against oxidative stress in diabetes mellitus: regulation of glutathione synthesis and efflux. Diabetologia 1995; 38:201-210.
14. Nwose E, Jelinek H, Richards R. Changes in malondialdehyde level in diabetes. The Australian Health and Medical Research Congress, Sydney. 208, 2004.
15. Callum L, James D. Targeting therapeutics against glutathione depletion in diabetes and its complications. Br J Diabetes Vasc Dis 2007; 7:258-265.
16. Hochstein P, Atallah AS. The nature of oxidants and antioxidant systems in the inhibition of mutation and cancer. Mutat Res 1988; 202: 363-375.
17. Neilsen F, Mikkelsen B, Neilsen J, Andersen H, Grandjean P. Plasma malondialdehyde as biomarker for oxidative stress reference interval and effects of life-style factors. Clin Chem 1997; 47:1209-1214.
18. Slatter DA, Bolton CH, Bailey AJ. The importance of lipid-derived malondialdehyde in diabetes mellitus. Diabetologia 2000; 43: 550-557.
19. Lucijan M. The level of maternal methemoglobin during pregnancy in an air-polluted environment. Environ Health Perspect 2003; 111:1902-1905.
20. Balla J, Balla G, Jeney V, Kakuk G, Jacob H, Vercelloti G. Ferriporphyrins and endothelium. A 2-edged sword. Promotion of oxidation and induction of cytoprotectants. Blood 2000; 95: 3442-3450.
21. Loft S, Poulsen HE. Cancer risk and oxidative DNA damage in man. J MolMed 1966; 74: 297-312.
22. Tuzgen S, Hanimoglu H, Tanriverdi T et al. Relationship between DNA damage and total antioxidant capacity in patients with glioblastoma multiforme. Clin Oncol 2007; 19:177-181.
23. Le Page F, Margot A, Grollman AP, Sarasin A, Gentile A. Mutagenicity of a unique 8-oxoguanine in a Ha-ras sequence in mammalian cells. Carcinogenesis 1995; 16:2779-2784.
24. American Diabetes Association. Diagnosis and classification of diabetes mellitus. Diabetes Care 2004; 27: s5-s10.
25. Stocks J, Dormandy TL. The autooxidation of human red cell lipids induced by hydrogen peroxide. Br J Haematol 1971; 20:95-111.
26. Evelyn K, Malloy H. Microdetermination of oxyhemoglobin, methemoglobin and sulfhemoglobin in a single sample of blood. J Biol Chem 1938; 126: 655.
27. Noiri E, Nakao A, Uchida K et al. Oxidative and nitrosative stress in acuterenal ischemia. Am J Physiol 2001; 281: F948-F957.
28. Beutler E, Duran O, Kelly BM. Improved method for the determination of blood glutathione. J Lab Clin Med 1963; 64:822-888.
29. Lowry O, Passonneau J, Hasselberger F, Schulz D. Effects of ischemia on known substrates and cofactors of the glycolytic pathway in the brain. J Biol Chem 1964; 239:18.
30. Hinokio Y, Suzuki M, Hirai M, Chiba M, Hirai A, Toyota T. Oxidative DNA damage in diabetes mellitus: its association with diabetic complications. Diabetologia 1999; 42:995-998. (Pubitemid 29369608)
31. Nwose E, Jelinek H, Richards R, Kerr P. Erythrocyte oxidative stress in clinical management of diabetes and its cardiovascular complications. Br JBiomedSci 2007; 64: 35-43.
32. Bj0rnhjolt JV, Erikssen G, Aaser E et al. Fasting blood glucose: an underestimated risk factor for cardiovascular death: results from a 22-year follow-up of healthy non-diabetic men. Diabetes Care 1999; 22: 45-49.
33. Deedwania P, Fonseca V. Diabetes, prediabetes, and cardiovascular risk: shifting the paradigm. Am J Med 2005; 118:939-947.
34. Levitan EB, Song Y, Ford ES, Liu S. Is nondiabetic hyperglycemia a risk factor for cardiovascular disease? A meta-analysis of prospective studies. Arch Intern Med2004; 164: 2147-2155.
35. American Diabetes Association. Diagnosis and classification of diabetes mellitus. Diabetes Care 2005; 28 (Suppl 1): S37-S42.
36. Baynes J, Thorpe S. Role of oxidative stress in diabetic complications. Diabetes Care 1999; 48:1-9.
37. Suzuki S, Hinokio Y, Komatsu K et al. Oxidative damage to mitochondrial DNA and its relationship to diabetic complications. Diabetes Res Clin Pract 1999; 45:161-168. (Pubitemid 29457764)
38. Maura L, Lisa G, Vanessa P, Ellisabeta B, Gianluca B, Carlo Maria R. Oxidative DNA damage and plasma antioxidant capacity in type 2 diabetic patients with good and poor glycemic control. Mutat Res 2008; 638: 98-102.
39. Choi S, Choi H, Lee S, Ko S, You H, Ye S. Anti-inflammatory effect of 8- hydroxy-2′-deoxyguanosine on lipopolysaccharide-induced inflammation via rac suppression in Balb/c mice. Free Radic Biol Med 2007; 43: 1594-1603.
40. Kim J, Choi S, Yoo J, Chung M. 8-oxoguanine induces intramolecular DNA damage but free 8-oxoguanine protects intermolecular DNA from oxidative stress. FEBS Lett 2004; 556:104-110.
41. Ro JY Kim DY Park JW, Chung MH. Effects of 7,8-dihydro-8-oxo- deoxyguanosine on antigen challenge in ovalbumin-sensitized mice may be mediated by suppression of rac. Br J Pharmacol 2009; 158:1743-1752.
42. Dyer RG, Stewart MW Mitcheson J, George K, Alberti MM, Laker MF. 7-Ketocholesterol, a specific indicator of lipoprotein oxidation, and malondialdehyde in non-insulin dependent diabetes and peripheral vascular disease. Clin ChimActa 1998; 260:1-13.
43. Dincer Y Akcay T, Alademir Z, Ilkova H. Effect of oxidative stress on glutathione pathway in red blood cells from patients with insulin- dependent diabetes mellitus. Metabolism 2002; 51:1360-1362.
44. Woo KS, Chook P, Lolin YI et al. Hyperhomocyst(e)inemia is a risk factor for arterial endothelial dysfunction in humans. Am Heart J 1997; 96: 2542-2544.